Optimizing HIV Prevention and Care for Transgender Adults

Jordan E. Lake; Jesse L. Clark

Disclosures

AIDS. 2019;33(3):363-375. 

In This Article

Abstract and Introduction

Abstract

Transgender women have recently been acknowledged as a unique and important risk group in HIV research and care. Although transgender men also face specific problems related to HIV infection, less is known about the risk behaviours and HIV prevalence of this important population. This article highlights key issues relating to the epidemiology, prevention, treatment and management of complications of HIV infection in transgender adults living with HIV, and explores future areas for HIV-related research, with the ultimate goal of improving healthcare provision and quality of life for transgender persons worldwide.

Introduction

Transgender women have recently been acknowledged as a unique and important risk group in HIV research and care. Although transgender men also face specific problems related to HIV infection, less is known about risk behaviours and HIV prevalence among transgender men. Following the lead of public health efforts that address the high frequency of HIV infection among transgender women and the sociostructural factors contributing to HIV risk in this population, researchers have increasingly emphasized transgender-specific aspects of the epidemiology, prevention, treatment and management of complications of HIV infection.[1,2] Here, we seek to highlight key issues within these distinct areas, identify areas of overlap and importance between social scientific and biomedical disciplines, and explore future areas for HIV-related research in transgender adults.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....